Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population-Reference-Cited by-同舟云学术

Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population

Published:2010-09-15 Issue:4 Volume:80 Page:375-382
ISSN:0009-9163
Container-title:Clinical Genetics
language:en
Short-container-title:

Author:

Pertesi M,Konstantopoulou I,Yannoukakos D

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0004.2010.01532.x/fullpdf

Reference31 articles.

1. Linkage of early-onset familial breast cancer to chromosome 17q21.;Hall;Science,1990

2. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.;Miki;Science,1994

3. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.;Puget;Cancer Res,1997

4. Genomic rearrangements in the BRCA1 and BRCA2 genes.;Mazoyer;Hum Mutat,2005

5. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation.;Sluiter;Breast Cancer Res Treat,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes;Cancers;2024-06-27

2. High prevalence of MUTYH associated polyposis among minority populations in Israel, due to rare founder pathogenic variants;Digestive and Liver Disease;2023-07

3. Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations;Familial Cancer;2022-05-21

4. CanVaS: Documenting the genetic variation spectrum of Greek cancer patients;Human Mutation;2021-07-06

5. BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects;International Journal of Cancer;2020-03-05